Post-Summer Skin Recovery: A Three-Stage Injectable Protocol for UV-Damaged Skin

Published: 2 September 2026

Every September the same patient profile walks into the clinic: skin that has spent three months in the sun and now arrives dehydrated, rough in texture, with a barrier that no longer holds water and a dermal matrix carrying the full cost of that exposure. This guide sets out a staged post-summer skin treatment plan built on injectables: why hydration, revitalisation and matrix repair are separate objectives, which product class serves each one, and how to sequence them over the first ten weeks of autumn.

What a summer of UV exposure actually does to the skin

The first visible change after summer is a loss of water-holding capacity, and it is a barrier problem before it is a dermal one. Chronic UV exposure disorganises stratum corneum lipids and alters the mechanical properties of the outer skin layers, which raises transepidermal water loss and leaves the epidermis unable to retain the moisture it is given. ^[1] Clinically this is the patient whose skin looks dull and tight in the morning regardless of topical routine: the reservoir is leaking faster than it can be refilled, so surface products underperform until the barrier is addressed.

Beneath the barrier, the same exposure has been working on the extracellular matrix. UV radiation drives the expression of matrix metalloproteinases, which degrade collagen and elastin fibres, while simultaneously suppressing new collagen synthesis by dermal fibroblasts. ^[2] Repeated over a season, this produces fragmented, disorganised collagen and a measurable drop in dermal density that is not yet visible as a wrinkle but is already visible as loss of firmness and a coarser, less elastic texture. ^[3] This is the deficit that a hydrating skin booster cannot correct, because photoaged skin treatment at this level is structural rather than volumetric.

The practical consequence is that no single product resolves UV-damaged skin, and attempting to treat it with one usually means treating the barrier and calling the job done. Hydration, revitalisation and matrix repair are three distinct biological objectives with three distinct formulation logics, and skin recovery after sun works best when they are introduced in order: rebuild water retention first, so that the tissue tolerates and uses fuller formulations, then drive regeneration once the dermis is in a condition to respond to it. The remainder of this article follows that order.

Best injectable treatments after summer

The injectables after summer that earn their place in the plan are the ones that match a specific deficit rather than a general wish for “rejuvenation”. Low- and non-cross-linked hyaluronic acid skin boosters are the first-line treatment for UV-damaged skin because they act directly on the water deficit: high water-binding capacity, no added volume, minimal inflammatory load on tissue that is already reactive. ^[4] In the post-summer context they are not a luxury glow treatment but the preparatory step that makes everything afterwards work better.

The second group is revitalisation: multicomponent mesotherapy that replaces the vitamins, amino acids, minerals and antioxidants depleted by oxidative stress, and hybrid high-concentration HA complexes that remodel laxity at a tissue level. Both belong to skin rejuvenation after sun exposure because they address the two things a plain skin booster does not, oxidative damage and loss of firmness, and both benefit from a hydrated, tolerant dermis, which is why they sit in the second stage rather than the first.

The third group is regenerative: polynucleotides, and in selected patients other collagen stimulators, which act on fibroblasts and the extracellular matrix rather than on water content. They are one of the injectable classes specifically used to target fibroblast activity and extracellular matrix repair rather than water content alone, and they are also the class most often started too early. Photoaged skin treatment succeeds when these three groups are used as a sequence; the sections below take each stage in turn.

Stage one: hydration while the barrier recovers, weeks one to four

The opening stage has a narrow objective: restore dermal hydration while the epidermal barrier recovers through time and consistent topical support, so that texture normalises and the tissue can tolerate more complex formulations later. Injectable HA improves hydration and skin quality; it does not rebuild the stratum corneum, and the barrier itself remains the domain of topical care. Low-cross-linked or non-cross-linked hyaluronic acid is the tool for this, because its water-binding capacity works immediately at the level of the deficit without adding volume or provoking a strong inflammatory response in tissue that is already reactive. ^[4] This is not the moment for high-concentration bio-remodelling or nutrient-dense mesotherapy; those come once the barrier holds.

For skin showing visible surface change after summer, the combination of hyaluronic acid with glycerol in Belotero Revive is designed for exactly this indication: the glycerol supports epidermal water retention while the cohesive HA gel improves roughness, fine lines and radiance in early photoageing. The published early-intervention data on CPM-HA20G show improvement in skin hydration and elasticity that persists for several months after a short series of sessions. ^[4] In practice it suits the face, neck, décolletage and hands where barrier compromise has already produced altered texture rather than dryness alone.

Where the tissue is reactive, mature or heavily photodamaged, the lower-irritation option is pure, additive-free hyaluronic acid. Ejal40 delivers 40 mg of high-molecular-weight non-cross-linked HA in 2 ml, injected through a four-point technique per side, and its value in this stage is precisely its simplicity: there is nothing in the syringe for sensitised skin to react to, and the hydration effect is rapid. The wider selection of hydration-focused skin boosters covers the remaining concentration and molecular-weight options for practitioners who want to match viscosity to a specific anatomical zone.

Stage two: revitalisation and bio-remodelling in weeks four to ten

Once the barrier holds water, the dermis can be given more to work with. The second stage introduces fuller formulations, either nutrient-rich mesotherapy that replenishes the raw materials depleted fibroblasts need, or high-concentration HA complexes that remodel laxity at a tissue level. The reason for the interval is tolerance and efficiency: in clinical practice, introducing more complex formulations after an initial hydration phase tends to improve tolerability and makes the overall treatment plan easier to sequence.

The mesotherapy option with the strongest clinical evidence for multi-zone use is Fillmed NCTF 135 HA , a non-cross-linked HA carrying a complex of vitamins, amino acids, minerals, coenzymes and antioxidants. In the HEBE2 randomised, active-controlled multicentre trial, NCTF 135HA significantly reduced wrinkles and improved radiance across face, neck and décolletage at day 75 and day 120 compared with an active cream control. ^[5] For post-summer skin the antioxidant and micronutrient content is the relevant feature: it addresses the oxidative component of the damage rather than only the water deficit.

Where the dominant complaint is laxity and loss of firmness rather than surface texture, bio-remodelling with hybrid cooperative HA complexes is the more direct answer. Profhilo H+L combines high- and low-molecular-weight HA at 64 mg per 2 ml without chemical cross-linking, delivered in two sessions four weeks apart through five bio-aesthetic points per side; the technique was designed to minimise injection points and downtime while spreading the product across the treated area. ^[6] In an autumn skin protocol the two approaches are not mutually exclusive: NCTF for the oxidative and radiance deficit, Profhilo where laxity is the leading complaint.

Stage three: matrix repair with polynucleotides from week six

The final stage targets the structural deficit that summer leaves in the dermis: fragmented collagen, disorganised elastin and fibroblasts that have been pushed towards a degradative rather than a synthetic state. Polynucleotides act on this directly. They engage adenosine A2A receptors on fibroblasts, promoting cell proliferation and matrix deposition, and they provide a purine and pyrimidine substrate that supports tissue repair, which is why the polynucleotide consensus literature positions them as a regenerative rather than a hydrating or volumising class. ^[7] Starting from week six, once stages one and two have restored hydration and tolerance, gives the fibroblasts a better environment in which to respond.

For the standard post-summer presentation, Nucleofill Medium at 2% polynucleotide concentration is the appropriate entry point: it delivers the matrix-repair signal without the density of the stronger formulation and suits skin that has completed the earlier stages and now needs regeneration rather than further hydration. Its profile also includes antioxidant activity, which is relevant when the underlying insult has been oxidative, and preclinical work on polynucleotide gels shows enhanced matrix deposition and organisation in repairing tissue. ^[8]

Where the deficit is deeper, with visible loss of density and firmness in mature or heavily photodamaged skin, the 2.5% formulation in Nucleofill Strong is the stronger regenerative signal for the same mechanism, at the cost of a slightly longer treatment interval. Polynucleotides are one option within a broader group of collagen-stimulating products, and comparing them with calcium hydroxylapatite and PLLA-based alternatives is worthwhile when a longer scaffold effect is the clinical priority.

Why fillers are not the first step after summer

A common request in September is volume: the patient has noticed hollowing, flatter cheeks or a heavier lower face and asks for filler. Some of that perception is real loss of dermal density, some is the optical effect of dehydrated, rough skin that no longer reflects light evenly. Cross-linked HA fillers correct the first and do nothing for the second, and injected into thin, dehydrated, matrix-depleted tissue they can look overfilled, sit superficially and integrate poorly.

The Fräya position, and the position taken throughout this protocol, is that tissue quality is restored first and volume is corrected afterwards. A hydrated dermis with an intact barrier and an active fibroblast population provides a better bed for any structural product: better integration, a more natural surface, and in many cases a smaller volume requirement once the skin quality deficit has been resolved. The dotted last box in the diagram above is deliberate: dermal fillers belong at the end of the autumn plan, not at the start.

The same logic applies to choosing between regenerative classes. Polynucleotides, PLLA and calcium hydroxylapatite are not interchangeable, differ in mechanism and tissue depth, and suit different patient profiles; the decision is clinical rather than commercial, and our separate guide on how to choose a biostimulator sets out the selection criteria in detail. For the specific post-summer indication, polynucleotides are the usual first choice because they act on the matrix without adding scaffold volume to tissue that is still recovering.

Sequencing the three stages in practice

Timing	Objective	Product class	Example products
Weeks 1–4	Restore hydration while supporting barrier recovery	Low- or non-cross-linked HA skin boosters	Belotero Revive, Ejal40
Weeks 4–10	Revitalise; remodel laxity	Multicomponent mesotherapy; hybrid HA bio-remodelling	Fillmed NCTF 135 HA, Profhilo H+L
From week 6	Fibroblast stimulation and ECM repair	Polynucleotides	Nucleofill Medium, Nucleofill Strong
After week 10	Structural volume correction, if still indicated	Cross-linked HA fillers	Per indication

The stages overlap by design. Stage three begins at week six, while stage two may still be running, because polynucleotides and HA-based revitalisation act through different pathways and do not compete for the same tissue response. The interval between stage one and the fuller formulations is the part worth protecting: allowing around four weeks gives the barrier time to recover before more intensive formulations are introduced, and in clinical practice this tends to improve tolerability and makes the response to the later stages easier to assess.

Patient selection within the sequence follows the dominant deficit rather than the calendar. A patient with intact firmness but rough, dehydrated surface skin may need only stages one and two; a patient whose main complaint is loss of density after years of unprotected exposure may move quickly through stage one and spend longer on polynucleotides. In higher phototypes, where post-inflammatory hyperpigmentation is the main summer-season concern, the lower-irritation options in each stage, additive-free HA and polynucleotides, are the safer default.

Timing the whole plan for September is not arbitrary. Barrier repair takes roughly a month to consolidate, bio-remodelling and mesotherapy show their effect over the following six to eight weeks, and polynucleotide-driven matrix repair develops progressively over two to three months. A post-summer skin treatment plan started in the first weeks of autumn therefore reaches its full effect before the winter season, and leaves the dermis in better condition for any structural or filler work planned later in the year.

Who benefits most from this protocol

The clearest candidate is the patient with cumulative, unprotected sun exposure over the summer, typically presenting in early September with dull, tight, rough skin and a history of applying sunscreen inconsistently or only to the face. In this group the barrier deficit is pronounced, the oxidative load is high, and all three stages are usually indicated; the visible response to stage one alone is often enough to secure commitment to the rest of the plan.

The second group is mature and peri- or post-menopausal skin, where a summer of UV exposure lands on a dermis that was already losing collagen at an accelerated rate. Here the emphasis shifts towards stages two and three: revitalisation to replace depleted substrate and polynucleotides to restore matrix synthesis, with the hydration stage kept short and, where the tissue is reactive, built on additive-free HA. This is also the profile in which a practitioner may consider whether a higher-concentration regenerative formulation is appropriate, depending on tissue quality and treatment history.

The third group is the patient who already has facial fillers or biostimulators in place and whose existing work now looks less refined because the surrounding skin quality has dropped. For this patient the protocol is maintenance of the investment rather than a new treatment: restoring hydration and matrix quality around existing volume typically improves how that volume reads, and it defers or reduces the need for touch-up filler. Patients with active inflammatory skin disease, recent sunburn or an ongoing tan should wait until the skin has settled before starting any of the three stages.

Common mistakes after summer

Starting collagen stimulation before addressing marked dehydration. In patients with visibly dehydrated or reactive post-summer skin, moving directly to regenerative treatments may make the response harder to assess and the overall plan less tolerable. Biostimulators and polynucleotides ask fibroblasts to synthesise new matrix, and the tissue environment they are delivered into influences how that response develops. Addressing hydration first is a sequencing choice that keeps the later stages easier to evaluate, not a delay in the plan.

Treating UV damage with fillers only. Volume loss after summer is partly real and partly optical, and cross-linked HA corrects only the first. Filler placed into rough, dehydrated, matrix-depleted skin often looks overcorrected and integrates poorly. Restore tissue quality first, then reassess how much volume is actually still missing; the answer is frequently less than the patient expected.

Ignoring barrier recovery. Treating the whole presentation as a dermal problem misses the fact that the epidermis is leaking water faster than any injectable can replace it. Stage one exists because the barrier deficit is real and measurable, and pairing the hydration phase with consistent topical barrier support gives the later stages a better-prepared tissue to work in.

Using aggressive resurfacing immediately after prolonged UV exposure. Ablative or deep resurfacing on skin that has just spent three months in the sun, particularly in higher phototypes, carries an elevated risk of post-inflammatory hyperpigmentation and prolonged recovery. The injectable sequence described here is the lower-risk route to the same skin-quality objective, and any resurfacing planned for the season is better scheduled after the barrier and matrix have been restored.

In conclusion, post-summer skin is not one problem but three, and the order of treatment matters as much as the products chosen. Restore hydration and barrier function first, revitalise and remodel once the tissue tolerates it, then repair the matrix with polynucleotides from week six. Started in early September, the full sequence reaches its effect before winter and leaves the skin in the best possible condition for any structural work that follows.

Fräya Med Supply carries a curated portfolio of skin boosters, mesotherapy products, polynucleotides and collagen stimulators that can be combined into post-summer treatment plans according to individual patient needs. The product categories referenced throughout this guide set formulations and indications side by side, so that each stage of the protocol can be matched to the tissue in front of you rather than to a fixed product list.

FAQ

What is the best injectable treatment for skin after summer?

There is no single best product, because post-summer skin has three separate deficits. A low- or non-cross-linked HA skin booster is the right first step; mesotherapy or bio-remodelling follows, and polynucleotides address the matrix damage from week six.

Can the three stages be started at the same time?

Not recommended. Fuller formulations delivered into barrier-compromised, dehydrated skin tend to produce more reaction and less uptake. Restore hydration for about four weeks first, then introduce revitalisation, with polynucleotides from week six onwards.

How soon after summer can treatment begin?

As soon as there is no active sunburn or inflammation and daily UV exposure has dropped. Early September is ideal, because the barrier-repair stage then consolidates before the fuller formulations are introduced in October.

Which stage is most important if the patient can only commit to one?

Stage one. Restoring hydration produces the most visible early change and prepares the tissue for anything added later. Matrix repair without prior hydration tends to underperform and is harder for the patient to tolerate.

Are polynucleotides suitable for darker phototypes after summer?

Yes. Polynucleotides are among the lower-irritation regenerative options and carry a favourable profile where post-inflammatory hyperpigmentation is a concern. Standard phototype precautions still apply, including avoiding treatment on inflamed or freshly tanned skin.

References

1. Biniek K, Levi K, Dauskardt RH. Solar UV radiation reduces collagen in the skin barrier and disrupts its mechanical function. Proceedings of the National Academy of Sciences. 2012;109(42):17111–17116. DOI
2. Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Archives of Dermatology. 2002;138(11):1462–1470. DOI
3. Rittié L, Fisher GJ. Natural and sun-induced aging of human skin. Cold Spring Harbor Perspectives in Medicine. 2015;5(1):a015370. DOI
4. Hertz-Kleptow D, Hanschmann A, Hofmann M, Reuther T, Kerscher M. Facial skin revitalization with CPM-HA20G: an effective and safe early intervention treatment. Clinical, Cosmetic and Investigational Dermatology. 2019;12:563–572. DOI
5. Fanian F, et al. HEBE2 study: efficacy and safety of NCTF 135HA on face, neck and décolleté. Journal of Dermatological Treatment. 2023;34(1):2216323. DOI
6. Laurino C, Palmieri B, Coacci A. Efficacy, safety, and tolerance of a new injection technique for high- and low-molecular-weight hyaluronic acid hybrid complexes. Eplasty. 2015;15:e46. PubMed
7. Cavallini M, Bartoletti E, Maioli L, et al. Consensus report on the use of PN-HPT (polynucleotides highly purified technology) in aesthetic medicine. Journal of Cosmetic Dermatology. 2021;20(3):922–928. DOI
8. Colangelo MT, Govoni P, Belletti S, Squadrito F, Guizzardi S, Galli C. Polynucleotide biogel enhances tissue repair, matrix deposition and organization. Journal of Biological Regulators and Homeostatic Agents. 2021;35(1):355–362. PubMed